Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia
Open Access
- 12 October 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Abstract
Beyond its clinical diversity and severity, acute myeloid leukemia (AML) is known for its complex molecular background and for rewiring biological processes to aid disease onset and maintenance. FLT3 mutations are among the most recurring molecular entities that cooperatively drive AML, and their inhibition is a critical molecularly oriented therapeutic strategy. Despite being a promising avenue, it still faces challenges such as intrinsic and acquired drug resistance, which led us to investigate whether and how autophagy and inflammasome interact and whether this interaction could be leveraged to enhance FLT3 inhibition as a therapeutic strategy. We observed a strong and positive correlation between the expression of key genes associated with autophagy and the inflammasome. Gene set enrichment analysis of the FLT3-ITD samples and their ex vivo response to five different FLT3 inhibitors revealed a common molecular signature compatible with autophagy and inflammasome activation across all poor responders. Inflammasome activation was also shown to strongly increase the likelihood of a poor ex vivo response to the FLT3 inhibitors quizartinib and sorafenib. These findings reveal a distinct molecular pattern within FLT3-ITD AML samples that underscores the necessity for further exploration into how approaching these supportive parallel yet altered pathways could improve therapeutic strategies.Keywords
All Related Versions
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2022/03871-1, #2021/11112-0, #2013/08135-2)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887.650052/2021-00)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (465539/2014-9)
This publication has 48 references indexed in Scilit:
- The relevance of the hematopoietic niche for therapy resistance in acute myeloid leukemiaInternational Journal of Cancer, 2023
- Frightening Fever: Familial Cold Autoinflammatory Syndrome 2 (FCAS-2) with Macrophage Activation Syndrome (MAS)Indian Journal of Pediatrics, 2022
- Inflammasome activation: from molecular mechanisms to autoinflammationClinical & Translational Immunology, 2022
- Autophagy as an integral immune system component2022
- An overview of autophagy: Mechanism, regulation and research progressBulletin du Cancer, 2021
- TRIM Proteins in Inflammation: from Expression to Emerging Regulatory MechanismsInflammation, 2021
- Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic ImplicationsCurrent Oncology Reports, 2020
- Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and ImmunityCell, 2019
- Mitochondrial Dysfunction in Stroke: Implications of Stem Cell TherapyTranslational Stroke Research, 2018
- Molecular biomarkers in acute myeloid leukemiaBlood Reviews, 2017